Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000304
Chunk: 19

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 19
---
 paid within   
 fourteen (14) clear days following the giving of a notice to the holder (or any person entitled by transmission to the share) demanding 
 payment of the amount due within such fourteen (14) clear day period and stating that if the notice is not complied with the shares may 
 be sold.                                                                                                                                |

| 17.2 | To give effect to such sale the Board may: |

| (A) | in the case of certificated shares, authorise a person to execute an instrument of transfer of shares                                        
 in the name and on behalf of the holder of, or the person entitled by transmission to, them to the purchaser or as the purchaser may direct; 
 and                                                                                                                                          |

| (B) | in the case of uncertificated shares, exercise any power conferred on it by Article 15.10 (uncertificated 
 shares) to effect a transfer of the shares.                                                               |

| 12 |

| 17.3 | The purchaser will not be bound to see to the application of the purchase monies in respect of any such                                   
 sale, nor will its title to the shares be affected by any irregularity in or invalidity of the proceedings connected with the sale or     
 transfer. Any instrument or exercise referred to in Article 17.2 shall be effective as if it had been executed or exercised by the holder 
 of, or the person entitled by transmission to, the shares to which it relates.                                                            |

| 18 | APPLICATION OF SALE PROCEEDS |

The net proceeds of any sale of shares
subject to the Company’s lien under these Articles (after payment of the costs and expenses of sale) shall be applied in or towards
satisfaction of the amount then due to the Company in respect of the shares. Any balance shall be paid to the original holder of, or the
person entitled (but for such sale) by transmission to, the shares on (in the case of certificated shares) surrender to the Company for
cancellation of the certificate for such shares and (in all cases) subject to the Company having a lien on such balance on the same basis
as applied to such shares for any amount not presently payable as existed on such shares before the sale.

| 19 | CALLS |

| 19.1 | Subject to the terms on which shares are allotted, the Board may make calls on the members (and any persons                                 
 entitled by transmission) in respect of any amounts unpaid on their shares (whether in respect of nominal value or